249 related articles for article (PubMed ID: 16008004)
61. Triple therapy vs. dual bronchodilator therapy for chronic obstructive pulmonary disease: Is it worth the cost?
Horita N; Kaneko T
Respir Investig; 2015 Jul; 53(4):173-5. PubMed ID: 26100178
[No Abstract] [Full Text] [Related]
62. [Increased dosage of inhaled corticosteroids or addition of salmeterol in symptomatic asthma].
Jébrak G
Presse Med; 2000 Sep; 29(27):1512-3. PubMed ID: 11045121
[No Abstract] [Full Text] [Related]
63. [Adding an anti-leukotriene: results of the IMPACT study].
Lipworth B
Rev Pneumol Clin; 2003 Sep; 59(4):261-7. PubMed ID: 14705613
[No Abstract] [Full Text] [Related]
64. Asthma exacerbations and formoterol.
Rissmiller RW; Larj MJ; Peters SP; Bleecker ER
Chest; 2004 Apr; 125(4):1590-1. PubMed ID: 15078782
[No Abstract] [Full Text] [Related]
65. Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D.
Anzueto A; Jenkins CR; Make BJ; Lindberg M; Calverley PM; Fagerås M; Postma DS; Rennard SI; Tashkin DP
Eur Respir J; 2015 Jul; 46(1):255-8. PubMed ID: 26022947
[No Abstract] [Full Text] [Related]
66. [Rapid effectiveness and better medication compliance].
Gessner C
MMW Fortschr Med; 2014 Oct; 156(17):67. PubMed ID: 25417481
[No Abstract] [Full Text] [Related]
67. The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids.
Lanes SF; Jara M
Am J Respir Crit Care Med; 2008 Sep; 178(5):543-4; author reply 544. PubMed ID: 18713851
[No Abstract] [Full Text] [Related]
68. Inhaled therapy for stable chronic obstructive pulmonary disease.
Antoniu SA; Mihaescu T; Donner CF
Expert Opin Pharmacother; 2007 Apr; 8(6):777-85. PubMed ID: 17425473
[TBL] [Abstract][Full Text] [Related]
69. Five questions in chronic obstructive pulmonary disease.
Miravitlles M
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):1-2. PubMed ID: 23551018
[No Abstract] [Full Text] [Related]
70. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro.
O'Byrne PM
Am J Respir Crit Care Med; 2005 Aug; 172(4):410-2; discussion 415-6. PubMed ID: 16081553
[No Abstract] [Full Text] [Related]
71. Combination of inhaled corticosteroid and bronchodilator-induced delirium in an elderly patient with lung disease.
Moss JM; Kemp DW; Brown JN
J Pharm Pract; 2014 Feb; 27(1):79-83. PubMed ID: 24097913
[TBL] [Abstract][Full Text] [Related]
72. New once-daily, long-acting inhaled β₂-agonist: what role will it play in the treatment of chronic obstructive pulmonary disease?
McIvor RA
Pol Arch Med Wewn; 2010 Oct; 120(10):381-2. PubMed ID: 20980942
[No Abstract] [Full Text] [Related]
73. [Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients].
Ruiz García V; Compte Torrero L
Med Clin (Barc); 2011 Sep; 137(7):302-4. PubMed ID: 21396667
[TBL] [Abstract][Full Text] [Related]
74. Managing chronic diseases: combination of inhaler treatment in India has shown good results.
Koul PA
BMJ; 2005 Apr; 330(7497):964; discussion 964-5. PubMed ID: 15845987
[No Abstract] [Full Text] [Related]
75. [Pharmacologic treatment of stable COPD].
Yamaguchi K
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):710-6. PubMed ID: 15455943
[No Abstract] [Full Text] [Related]
76. [COPD--comparison between once- and twice daily administration of formoterol]].
Schneider S
Pneumologie; 2007 Dec; 61(12):752. PubMed ID: 18275012
[No Abstract] [Full Text] [Related]
77. [Precise direction or flexible self-control. How strictly must the asthma patient adhere to medical advice?].
Gillissen A
MMW Fortschr Med; 2001 May; 143(19):52-3. PubMed ID: 11400630
[No Abstract] [Full Text] [Related]
78. Use of long-acting beta2 agonists in arginine-16 homozygous patients with asthma.
Green RH; Pavord ID
Thorax; 2008 Jun; 63(6):568-9. PubMed ID: 18511645
[No Abstract] [Full Text] [Related]
79. Optimising treatment for COPD--new strategies for combination therapy.
Welte T
Int J Clin Pract; 2009 Aug; 63(8):1136-49. PubMed ID: 19624783
[TBL] [Abstract][Full Text] [Related]
80. FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease.
Muir JF; Benhamou D; Cuvelier A; Le Gros V; Overend T; Till D; Della Cioppa G; Kottakis J
Int J Clin Pract; 2004 May; 58(5):457-64. PubMed ID: 15206501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
